Free Trial
ASX:CUV

Clinuvel Pharmaceuticals (CUV) Stock Price, News & Analysis

Clinuvel Pharmaceuticals logo

About Clinuvel Pharmaceuticals Stock (ASX:CUV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
124,193 shs
Average Volume
N/A
Market Capitalization
A$563.18 million
P/E Ratio
15.95
Dividend Yield
0.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CUV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clinuvel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CUV Stock News Headlines

Clinuvel Pharmaceuticals Stock Price History
Why Elon is funding the “Quantum Power Grid”
Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly becoming one of the most profitable stories of the year.
High Growth Tech Stocks In Australia For March 2025
See More Headlines

CUV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Clinuvel Pharmaceuticals investors own include Cochlear (COH), CSL (CSL), ResMed (RMD), ARB (ARB), Accent Group (AX1), Corporate Travel Management (CTD) and Mineral Resources (MIN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CUV
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
15.95
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$35.64 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$88.18 million
Price / Cash Flow
19.36
Book Value
A$4.02 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$563.18 million
Optionable
Not Optionable
Beta
0.92
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (ASX:CUV) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners